RLMD vs. ANGPY
RLMD (Relmada Therapeutics, Inc.) and ANGPY (Anglo American Platinum ADR) are both stocks. RLMD operates in Biotechnology (Healthcare), while ANGPY operates in Other Precious Metals & Mining (Basic Materials). Over the past 10 years, RLMD returned -3.05%/yr vs 13.93%/yr for ANGPY. Their 0.10 correlation means their historical movements had little consistent relationship.
Performance
RLMD vs. ANGPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RLMD achieves a 9.94% return, which is significantly higher than ANGPY's -7.17% return. Over the past 10 years, RLMD has underperformed ANGPY with an annualized return of -3.05%, while ANGPY has yielded a comparatively higher 13.93% annualized return.
RLMD
- 1D
- -0.75%
- 1M
- -15.45%
- 6M
- 49.58%
- YTD
- 9.94%
- 1Y
- 799.39%
- 3Y*
- 27.53%
- 5Y*
- -27.22%
- 10Y*
- -3.05%
- ALL TIME*
- -18.56%
ANGPY
- 1D
- 0.56%
- 1M
- 7.99%
- 6M
- -11.07%
- YTD
- -7.17%
- 1Y
- 74.62%
- 3Y*
- 23.34%
- 5Y*
- -3.15%
- 10Y*
- 13.93%
- ALL TIME*
- 18.76%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.91M | $1.80M | $2.02M | |
| $8.35M | $9.37M | $10.80M |
RLMD vs. ANGPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RLMD Relmada Therapeutics, Inc. | 9.94% | 828.85% | -87.44% | 18.62% | -84.51% | -29.75% | -17.77% | 747.83% | 53.33% | -31.19% |
ANGPY Anglo American Platinum ADR | -7.17% | 202.15% | -40.10% | -34.38% | -19.08% | 30.87% | 6.85% | 163.52% | 31.10% | 49.21% |
Correlation
The correlation between RLMD and ANGPY is 0.19, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.19 |
Correlation (3Y) Balances recent behavior with more history. | 0.12 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.11 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.11 |
Correlation (All Time) Calculated using the full available price history since Jun 2, 2016 | 0.10 |
Fundamentals
RLMD:
$556.97M
ANGPY:
$19.80B
RLMD:
-$0.94
ANGPY:
ZAR 23.28
RLMD:
2.10
ANGPY:
3.05
RLMD:
$0.00
ANGPY:
ZAR 250.65B
RLMD:
$0.00
ANGPY:
ZAR 64.89B
RLMD:
-$60.34M
ANGPY:
ZAR 70.42B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RLMD vs. ANGPY — Risk / Return Rank
RLMD
ANGPY
RLMD vs. ANGPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Relmada Therapeutics, Inc. (RLMD) and Anglo American Platinum ADR (ANGPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RLMD | ANGPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +5.32 | ||
| Sortino ratioReturn per unit of downside risk | +3.95 | ||
| Omega ratioGain probability vs. loss probability | 1.63 | 1.21 | +0.41 |
| Calmar ratioReturn relative to maximum drawdown | 20.90 | 1.78 | +19.12 |
| Martin ratioReturn relative to average drawdown | 53.87 | 3.61 | +50.26 |
Loading charts...
Drawdowns
RLMD vs. ANGPY - Drawdown Comparison
The maximum RLMD drawdown since its inception was -99.66%, which is greater than ANGPY's maximum drawdown of -78.47%. Use the drawdown chart below to compare losses from any high point for RLMD and ANGPY.
Loading charts...
Drawdown Indicators
| RLMD | ANGPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.66% | -78.47% | -21.19% |
Max Drawdown (1Y)Largest decline over 1 year | -36.39% | -43.04% | +6.65% |
Max Drawdown (3Y)Largest decline over 3 years | -96.30% | -43.04% | -53.26% |
Max Drawdown (5Y)Largest decline over 5 years | -99.32% | -78.47% | -20.85% |
Max Drawdown (10Y)Largest decline over 10 years | -99.50% | -78.47% | -21.03% |
Current DrawdownCurrent decline from peak | -92.86% | -38.27% | -54.59% |
Average DrawdownAverage peak-to-trough decline | -79.84% | -35.26% | -44.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.10% | 21.18% | -7.08% |
Volatility
RLMD vs. ANGPY - Volatility Comparison
Relmada Therapeutics, Inc. (RLMD) has a higher volatility of 18.23% compared to Anglo American Platinum ADR (ANGPY) at 16.35%. This indicates that RLMD's price experiences larger fluctuations and is considered to be riskier than ANGPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RLMD | ANGPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.23% | 16.35% | +1.88% |
Volatility (6M)Calculated over the trailing 6-month period | 68.22% | 55.36% | +12.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 118.22% | 68.99% | +49.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 116.44% | 59.17% | +57.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 114.21% | 57.06% | +57.15% |
Dividends
RLMD vs. ANGPY - Dividend Comparison
RLMD has not paid dividends to shareholders, while ANGPY's dividend yield for the trailing twelve months is around 3.47%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
ANGPY Anglo American Platinum ADR | 3.47% | 3.87% | 3.40% | 4.85% | 15.62% | 10.20% | 2.91% | 0.99% | 1.11% |
RLMD Relmada Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
RLMD vs. ANGPY - Financials Comparison
This section allows you to compare key financial metrics between Relmada Therapeutics, Inc. and Anglo American Platinum ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RLMD and ANGPY have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RLMD has higher volatility (18.23%) compared to ANGPY (16.35%). In terms of maximum drawdown, RLMD dropped -99.66% vs ANGPY's -78.47%.
RLMD currently has the higher Sharpe Ratio (6.44 vs 1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RLMD and ANGPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer